-
Exposure-response analysis of oral and intravenous imatinib in critically ill patients with COVID-19 acute respiratory distress syndrome
Said, M. M., Braam, A. M., Duijvelaar, E., Schippers, J. R., Atmowihardjo, L., Twisk, J., Bogaard, H. J., Swart, E. L., Aman, J. & Bartelink, I. H., 1 Dec 2025, In: European journal of pharmaceutical sciences. 215, p. 107332 107332.Research output: Contribution to journal › Article › Academic › peer-review
-
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study
Rothman, A. M. K., Villar, S. S., Middleton, J., Roussakis, A. A., Varian, F., Zafar, H., Law, M., Apperley, J., Bartelink, I. H., Said, M. M., Delgado-SanMartin, J. A., Kiely, D. G., Howard, L., Toshner, M., Wort, S. J. & Wilkins, M. R., 1 Jun 2025, In: American Journal of Respiratory and Critical Care Medicine. 211, 6, p. 1018-1027 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Disease–Drug–Drug Interaction of Imatinib in COVID-19 ARDS: A Pooled Population Pharmacokinetic Analysis
Said, M. M., Schippers, J. R., Atmowihardjo, L., Li, Y., van der Plas, M. S., Bogaard, H. J., Bos, L. D. J., Mathôt, R. A. A., Aman, J., Swart, E. L. & Bartelink, I. H., Mar 2025, In: CPT: Pharmacometrics and Systems Pharmacology. 14, 3, p. 583-595 13 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
